Reteplase, Recombinant (Intravenous Route)
Name: Reteplase, Recombinant (Intravenous Route)
- Reteplase, Recombinant Intravenous Route brand name
- Reteplase, Recombinant Intravenous Route effects of
- Reteplase, Recombinant Intravenous Route the effects of
US Brand Name
No information is available on the relationship of age to the effects of reteplase in geriatric patients. However, the risk of serious bleeding from this medicine may be more likely in elderly patients .
|All Trimesters||C||Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.|
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
- Alteplase, Recombinant
- Dabigatran Etexilate
- Pentosan Polysulfate Sodium
- Protein C
- Reteplase, Recombinant